标题
NAFLD/NASH in patients with type 2 diabetes and related treatment options
作者
关键词
Hepatocellular ballooning, Fibrosis, Cirrhosis, Hepatocellular carcinoma, NAFLD score, Fatty liver index (FLI)
出版物
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume 41, Issue 5, Pages 509-521
出版商
Springer Nature
发表日期
2017-11-30
DOI
10.1007/s40618-017-0799-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes
- (2017) Alessandro Mantovani et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review
- (2017) Ryuki Hashida et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis
- (2017) A. L. L. Rocha et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus
- (2017) Alessandro Mantovani et al. PLoS One
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Association between hepatic steatosis and serum liver enzyme levels with atrial fibrillation in the general population
- (2016) Marcello Ricardo Paulista Markus et al. ATHEROSCLEROSIS
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?
- (2016) Christopher D. Byrne et al. DIABETOLOGIA
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) et al. DIABETOLOGIA
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Development and validation of a noninvasive prediction model for nonalcoholic steatohepatitis resolution after lifestyle intervention
- (2016) Eduardo Vilar-Gomez et al. HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Association between bone mineral density and nonalcoholic fatty liver disease in Korean adults
- (2016) S. H. Lee et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
- (2015) Guillaume Lassailly et al. GASTROENTEROLOGY
- Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: Findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop
- (2015) Arun J. Sanyal et al. HEPATOLOGY
- High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
- (2015) Paola Portillo-Sanchez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of aerobic exercise training dose on liver fat and visceral adiposity
- (2015) Shelley E. Keating et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease
- (2015) Alessandro Mantovani et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes
- (2015) Alessandro Mantovani et al. PLoS One
- CKD and Nonalcoholic Fatty Liver Disease
- (2014) Giovanni Targher et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort
- (2014) Alvaro Alonso et al. HEART
- UCP1 -3826 AG+GG genotypes, adiponectin, and leptin/adiponectin ratio in severe obesity
- (2014) G. Labruna et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- The association between retinal microvascular changes, metabolic risk factors, and liver histology in pediatric patients with non-alcoholic fatty liver disease (NAFLD)
- (2014) D. Liccardo et al. JOURNAL OF GASTROENTEROLOGY
- Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
- (2014) Giovanni Musso et al. PLOS MEDICINE
- Relationship between glucose metabolism and non-alcoholic fatty liver disease severity in morbidly obese women
- (2014) Giorgio Bedogni et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Non-alcoholic fatty liver disease is associated with an increased prevalence of atrial fibrillation in hospitalized patients with Type 2 diabetes
- (2013) Giovanni Targher et al. CLINICAL SCIENCE
- Do Therapeutic Bile Acids Hit the Sweet Spot of Glucose Metabolism in NAFLD?
- (2013) Saul J. Karpen GASTROENTEROLOGY
- Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2013) Bart Staels et al. HEPATOLOGY
- Non-Alcoholic Fatty Liver Disease Is Associated with an Increased Incidence of Atrial Fibrillation in Patients with Type 2 Diabetes
- (2013) Giovanni Targher et al. PLoS One
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology and the American Gastroenterological Association
- (2012) Naga Chalasani et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Liver and diabetes. A vicious circle
- (2012) Paola Loria et al. HEPATOLOGY RESEARCH
- Bariatric Surgery and Long-term Cardiovascular Events
- (2012) Lars Sjöström et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Nonalcoholic Fatty Liver Disease Is Associated With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes
- (2011) S. Bonapace et al. DIABETES CARE
- Fatty liver index and mortality: The cremona study in the 15th year of follow-up
- (2011) Giliola Calori et al. HEPATOLOGY
- Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER-medicare database
- (2011) Tania M. Welzel et al. HEPATOLOGY
- Endpoints and clinical trial design for nonalcoholic steatohepatitis
- (2011) Arun J. Sanyal et al. HEPATOLOGY
- Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus
- (2011) Chia-Hsuin Chang et al. HEPATOLOGY
- Impact of Metformin on the Prognosis of Cirrhosis Induced by Viral Hepatitis C in Diabetic Patients
- (2011) Gisèle Nkontchou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review
- (2011) Christian Thoma et al. JOURNAL OF HEPATOLOGY
- The Effect of Mediterranean Diet on Metabolic Syndrome and its Components
- (2011) Christina-Maria Kastorini et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort Study
- (2010) Leon A Adams et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study
- (2010) Beverley Balkau et al. BMC GASTROENTEROLOGY
- Bile Acids as Regulators of Hepatic Lipid and Glucose Metabolism
- (2010) Michael Trauner et al. DIGESTIVE DISEASES
- The Role of Non-Alcoholic Fatty Liver Disease in Cardiovascular Disease
- (2010) Gianluca Perseghin DIGESTIVE DISEASES
- Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway
- (2010) Nitika Arora Gupta et al. HEPATOLOGY
- Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection
- (2010) Brad Q. Starley et al. HEPATOLOGY
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
- (2010) Judith Ertle et al. INTERNATIONAL JOURNAL OF CANCER
- Large-scale population analysis reveals an extremely low threshold for “non-healthy” alanine aminotransferase that predicts diabetes mellitus
- (2010) Amir Shlomai et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase
- (2010) Shani Ben-Shlomo et al. JOURNAL OF HEPATOLOGY
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Presence of Coronary Plaques in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Nimer Assy et al. RADIOLOGY
- PTEN in liver diseases and cancer
- (2010) Marion Peyrou WORLD JOURNAL OF GASTROENTEROLOGY
- Elevated fasting plasma C-peptide occurs in non-diabetic individuals with fatty liver, irrespective of insulin resistance
- (2009) G. Perseghin et al. DIABETIC MEDICINE
- High- or Low-Carbohydrate Diets: Which Is Better for Weight Loss, Insulin Resistance, and Fatty Livers?
- (2009) Guenther Boden GASTROENTEROLOGY
- Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis
- (2009) Valérie Paradis et al. HEPATOLOGY
- Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels
- (2009) Robin Haring et al. HEPATOLOGY
- Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial
- (2009) Vlad Ratziu et al. HEPATOLOGY
- Nonalcoholic Fatty Liver Is Not Associated with Carotid Intima-Media Thickness in Type 2 Diabetic Patients
- (2009) Jean Michel Petit et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
- (2009) Sabrina Cipriani et al. JOURNAL OF LIPID RESEARCH
- Alanine aminotransferase, γ-glutamyltransferase (GGT) and all-cause mortality: results from a population-based Danish twins study alanine aminotransferase, GGT and mortality in elderly twins
- (2009) Abigail Fraser et al. LIVER INTERNATIONAL
- Hepatic Steatosis and Subclinical Cardiovascular Disease in a Cohort Enriched for Type 2 Diabetes: The Diabetes Heart Study
- (2008) Ryan L. McKimmie et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Identification and Characterization of Metabolically Benign Obesity in Humans
- (2008) Norbert Stefan ARCHIVES OF INTERNAL MEDICINE
- The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes
- (2008) S.G. Wannamethee et al. ATHEROSCLEROSIS
- Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults
- (2008) C.-H. Kim et al. DIABETIC MEDICINE
- Increased Liver Fat, Impaired Insulin Clearance, and Hepatic and Adipose Tissue Insulin Resistance in Type 2 Diabetes
- (2008) Anna Kotronen et al. GASTROENTEROLOGY
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started